SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-062303
Filing Date
2024-07-18
Accepted
2024-07-18 06:14:35
Documents
17
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0209603-6k_immuron.htm 6-K 12393
2 IMMURON CEO TO PRESENT AT EMERGING GROWTH CONFERENCE ea020960301ex99-1_immuron.htm EX-99.1 45750
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10371
4 GRAPHIC ex99-1_002.jpg GRAPHIC 3295
5 GRAPHIC ex99-1_003.jpg GRAPHIC 33801
6 GRAPHIC ex99-1_004.jpg GRAPHIC 214308
7 GRAPHIC ex99-1_005.jpg GRAPHIC 315766
8 GRAPHIC ex99-1_006.jpg GRAPHIC 315688
9 GRAPHIC ex99-1_007.jpg GRAPHIC 463592
10 GRAPHIC ex99-1_008.jpg GRAPHIC 262833
11 GRAPHIC ex99-1_009.jpg GRAPHIC 285714
12 GRAPHIC ex99-1_010.jpg GRAPHIC 278433
13 GRAPHIC ex99-1_011.jpg GRAPHIC 206424
14 GRAPHIC ex99-1_012.jpg GRAPHIC 339649
15 GRAPHIC ex99-1_013.jpg GRAPHIC 293949
16 GRAPHIC ex99-1_014.jpg GRAPHIC 349017
17 GRAPHIC ex99-1_015.jpg GRAPHIC 128064
  Complete submission text file 0001213900-24-062303.txt   4882441
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 241123649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)